Epigenetic signatures in stem cells and cancer stem cells

Epigenomics

Volumn 1, Issue 2, 2009, Pages 261-280

  Hernandez Vargas, Hector ^a   Sincic, Nino ^b   Ouzounova, Maria ^a   Herceg, Zdenko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cancer stem cells; Chromatin modifications; DNA methylation; Epigenetics; Histone modifications; MicroRNAs; Pluripotency; Sternness

Indexed keywords

HISTONE; MICRORNA;

ANIMAL; ANIMAL EMBRYO; BIOLOGICAL MODEL; CHROMATIN; DNA METHYLATION; EMBRYONAL CARCINOMA STEM CELL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PLURIPOTENT STEM CELL; REVIEW;

ANIMALS; CHROMATIN; DNA METHYLATION; EMBRYO, MAMMALIAN; EMBRYONAL CARCINOMA STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; MICE; MICRORNAS; MODELS, BIOLOGICAL; PLURIPOTENT STEM CELLS;

EID: 80052017738     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/EPI.09.19     Document Type: Review

References (187)

1. Bird A: Perceptions of epigenetics. Nature 447 (7143), 396-398 (2007).
2. Ledford H: Language: disputed definitions. Nature 455(7216), 1023-1028 (2008).
3. Feinberg AP, Ohlsson R, Henikoff S: The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7(1), 21-33 (2006).
4. Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007).
5. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006).
6. Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151), 318-324 (2007).
7. Yu J, Hu K, Smuga-Otto K et al.: Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928), 797-801 (2009).
8. Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917-1920 (2007).
9. Park IH, Zhao R, West J A et al.: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175), 141-146(2008).
10. Maherali N, Sridharan R, Xie W et al.: Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1(1), 55-70 (2007).
11. Hajkova P, Ancelin K, Waldmann T et al.: Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452(7189), 877-881 (2008).
12. Shukla V, Vaissiere T, Herceg Z: Histone acetylation and chromatin signature in stem cell identity and cancer. Mutat. Res. 637(1-2), 1-15 (2008).
13. Visvader JE, Indeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8(10), 755-768 (2008).
14. Evans MJ, Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819), 154-156 (1981).
15. Fuchs E, Segre JA: Stem cells: a new lease on life. Cell 100(1), 143-155 (2000).
16. Niwa H: Open conformation chromatin and pluripotency. Gen. Dev. 21(21), 2671-2676 (2007).
17. Cowan CA, Atienza J, Melton DA, Eggan K: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309(5739), 1369-1373 (2005).
18. Spivakov M, Fisher AG: Epigenetic signatures of stem-cell identity. Nat. Rev. Genet. 8(4), 263-271 (2007).
19. Azuara V, Perry P, Sauer S et al.: Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8, 532-538 (2006).
20. Bibikova M, Chudin E, Wu B et al.: Human embryonic stem cells have a unique epigenetic signature. Genome Res. 16(9), 1075-1083 (2006).
21. Bernstein BE, Mikkelsen TS, Xie X et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315-326 (2006).
22. Sparmann A, van Lohuizen M: Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6 (11), 846-856 (2006).
23. Meshorer E, Yellajoshula D, George E et al.: Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10(1), 105-116(2006).
24. Buszczak M, Spradling AC: Searching chromatin for stem cell identity. Cell 125(2), 233-236 (2006).
25. Bartova E, Krejci J, Harnicarova A, Kozubek S: Differentiation of human embryonic stem cells induces condensation of chromosome territories and formation of heterochromatin protein 1 foci. Differentiation 76(1), 24-32 (2008).
26. Bartova E, Galiova G, Krejci J et al.: Epigenome and chromatin structure in human embryonic stem cells undergoing differentiation. Dev. Dyn. 237(12), 3690-3702 (2008).
27. Levasseur DN, Wang J, Dorschner MO, Stamatoyannopoulos JA, Orkin SH: Oct4 dependence of chromatin structure within the extended NANOG locus in ES cells. Genes Dev. 22(5), 575-580 (2008).
28. Tiwari VK, Cope L, McGarvey KM, Ohm JE, Baylin SB: A novel 6C assay uncovers Polycomb-mediated higher order chromatin conformations. Genome Res. 18(7), 1171-1179(2008).
29. Tiwari VK, McGarvey KM, Licchesi JD et al.: PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol. 6(12), 2911-2927 (2008).
30. Kouzarides T: Chromatin modifications and their function. Cell 128(4), 693-705 (2007).
31. Strahl BD, Allis CD: The language of covalent histone modifications. Nature 403(6765), 41-45 (2000).
32. Ohm JE, McGarvey KM, Yu X et al.: A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39(2), 237-242 (2007).
33. Pan G, Tian S, Nie J et al.: Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1(3), 299-312 (2007).
34. Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K: Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J. 23(20), 4061-4071 (2004).
35. Lee TI, Jenner RG, Boyer LA et al.: Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125(2), 301-313 (2006).
36. Boyer LA, Plath K, Zeitlinger J et al.: Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091), 9-53 (2006).
37. Lee MG, Villa R, Trojer P et al.: Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318(5849), 447-450 (2007).
38. Lan F, Bayliss PE, Rinn JL et al.: A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449(7163), 689-694 (2007).
39. Agger K, Cloos PA, Christensen J et al.: UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449(7163), 731-734 (2007).
40. Sen GL, Webster DE, Barragan DI, Chang HY, Khavari PA: Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Gen. Dev. 22(14), 1865-1870 (2008).
41. Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M: Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 445(7124), 214-218 (2007).
42. Henikoff S, Ahmad K: Assembly of variant histones into chromatin. Annu. Rev. Cell Dev. Biol. 21, 133-153 (2005).
43. Hake SB, Allis CD: Histone H3 variants and their potential role in indexing mammalian genomes: the 'H3 barcode hypothesis'. Proc. Natl Acad. Sci. USA 103(17), 6428-6435 (2006).
44. Santenard A, Torres-Padilla ME: Epigenetic reprogramming in mammalian reproduction: contribution from histone variants. Epigenetics 4(2), 80-84(2009).
45. Dai B, Rasmussen TP: Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. Stem Cells 25(10), 2567-2574 (2007).
46. Rangasamy D, Berven L, Ridgway P, Tremethick DJ: Pericentric heterochromatin becomes enriched with H2A.Z during early mammalian development. EMBO J. 22(7), 1599-1607 (2003).
47. Rasmussen TP, Mastrangelo MA, Eden A, Pehrson JR, Jaenisch R: Dynamic relocalization of histone MacroH2Al from centrosomes to inactive X chromosomes during X inactivation. J. Cell Biol. 150(5), 1189-1198(2000).
48. Shaw ML, Williams EJ, Hawes S, Saffery R: Characterisation of histone variant distribution in human embryonic stem cells by transfection of in vitro transcribed mRNA. Mol. Reprod. Dev. 76(12), 1128-1142(2009).
49. Creyghton MP, Markoulaki S, Levine SS et al.: H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell 135(4), 649-661 (2008).
50. Wong LH, Ren H, Williams E et al.: Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Res. 19(3), 404-414 (2009).
51. Bird A: DNA methylation patterns and epigenetic memory. Gen. Dev. 16(1), 6-21 (2002).
52. Monk M, Boubelik M, Lehnert S: Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99(3), 371-382 (1987).
53. Bernstein BE, Meissner A, Lander ES: The mammalian epigenome. Cell 128(4), 669-681 (2007).
54. Farthing CR, Ficz G, Ng RK et al.: Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet. 4(6), E1000116(2008).
55. Irizarry RA, Ladd-Acosta C, Wen B et al.: The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41(2), 178-186 (2009).
56. Reik W: Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447(7143), 425-432 (2007).
57. Kafri T, Ariel M, Brandeis M et al.: Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Gen. Dev. 6(5), 705-714 (1992).
58. Freitag M, Selker EU: Controlling DNA methylation: many roads to one modification. Curr. Opin. Genet. Dev. 15(2), 191-199 (2005).
59. Turek-Plewa J, Jagodzinski PP: The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell. Mol. Biol. Lett. 10(4), 631-647 (2005).
60. Okano M, Bell DW, Haber DA, Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3), 247-257 (1999).
61. Li E, Bestor TH, Jaenisch R: Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6), 915-926 (1992).
62. Weih F, Nitsch D, Reik A, Schutz G, Becker PB: Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo. EMBO J. 10(9), 2559-2567 (1991).
63. Campanero MR, Armstrong MI, Flemington EK: CpG methylation as a mechanism for the regulation of E2F activity. Proc. Natl Acad. Sci. USA 97(12), 6481-6486 (2000).
64. Eden S, Hashimshony T, Keshet I, Cedar H, Thome AW: DNA methylation models histone acetylation. Nature 394(6696), 842 (1998).
65. Bird AP, Wolffe AP: Methylation-induced repression - belts, braces and chromatin. Cell 99(5), 451-454 (1999).
66. Bannister AJ, Zegerman P, Partridge JF et al.: Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410(6824), 120-124(2001).
67. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T: Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410(6824), 116-120 (2001).
68. Golan-Mashiach M, Dazard JE, Gerecht-Nir S et al.: Design principle of gene expression used by human stem cells: implication for pluripotency. FASEB J. 19(1), 147-149 (2005).
69. Jackson M, Krassowska A, Gilbert N et al.: Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol. Cell. Biol. 24(20), 8862-8871 (2004).
70. Zvetkova I, Apedaile A, Ramsahoye B et al.: Global hypomethylation of the genome in XX embryonic stem cells. Nat. Genet. 37(11), 1274-1279(2005).
71. Gangaraju VK, Lin H: MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10(2), 116-125(2009).
72. Wang Y, Keys DN, Au-Young JK, Chen C: MicroRNAs in embryonic stem cells. J. Cell. Physiol. 218(2), 251-255 (2009).
73. Kim KS, Kim JS, Lee MR, Jeong HS, Kim J: A study of microRNAs in silico and in vivo: emerging regulators of embryonic stem cells. FEBS J. 276(8), 2140-2149 (2009).
74. Berezikov E, Guryev V, van de Belt J et al.: Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120(1), 21-24(2005).
75. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, function. Cell 116(2), 281-297(2004).
76. John B, Enright AJ, Aravin A et al.: Human microRNA targets. PLoS Biol 2(11), E363 (2004).
77. Griffiths-Jones S: The microRNA registry. Nucleic Acids Res. 32(Database issue), D109-D111 (2004).
78. Landgraf P, Rusu M, Sheridan R et al.: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7), 1401-1414 (2007).
79. Ketting RF, Fischer SE, Bernstein E et al.: Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15(20), 2654-2659 (2001).
80. Bernstein E, Kim SY, Carmell MA et al.: Dicer is essential for mouse development. Nat. Genet. 35(3), 215-217 (2003).
81. Wienholds E, Koudijs MJ, van Eeden FJ, Cuppen E, Plasterk RH: The microRNA-producing enzyme Dicerl is essential for zebrafish development. Nat. Genet. 35(3), 217-218 (2003).
82. Sinkkonen L, Hugenschmidt T, Berninger P et al.: MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 15(3), 259-267 (2008).
83. Laurent LC, Chen J, Ulitsky I et al.: Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cell 26(6), 1506-1516 (2008).
84. Suh MR, Lee Y, Kim JY et al.: Human embryonic stem cells express a unique set of microRNAs. Dev. Biol. 270(2), 488-498 (2004).
85. Houbaviy HB, Murray MF, Sharp PA: Embryonic stem cell-specific microRNAs. Dev. Cell 5(2), 351-358 (2003).
86. Singh SK, Kagalwala MN, Parker-Thornburg J, Adams H, Majumder S: REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 453(7192), 223-227 (2008).
87. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I: MicroRNAs to NANOG, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455(7216), 1124-1128(2008).
88. Conaco C, Otto S, Han JJ, Mandel G: Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl Acad. Sci. USA 103(7), 2422-2427 (2006).
89. Morin RD, O'Connor MD, Griffith M et al.: Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 18(4), 610-621 (2008).
90. Li SS, Yu SL, Kao LP et al.: Target identification of microRNAs expressed highly in human embryonic stem cells. J. Cell. Biochem. 106(6), 1020-1030 (2009).
91. Cao H, Yang CS, Rana TM: Evolutionary emergence of microRNAs in human embryonic stem cells. PLoS ONE 3(7), E2820 (2008).
92. Bussing I, Slack FJ, Grosshans H: Let-7 microRNAs in development, stem cells and cancer. Trends Mol. Med. 14(9), 400-409 (2008).
93. Benetti R, Gonzalo S, Jaco I et al.: A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rb12-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Biol. 15(9), 998 (2008).
94. Stingl J, Caldas C: Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat. Rev. Cancer 7(10), 791-799 (2007).
95. Lapidot T, Sirard C, Vormoor J et al.: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464), 645-648 (1994).
96. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3(7), 730-737 (1997).
97. Sirard C, Lapidot T, Vormoor J et al.: Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87(4), 1539-1548 (1996).
98. Kong Y, Yoshida S, Saito Y et al.: CD34'CD38'CD19' as well as CD34'CD38 CD19' cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 22(6), 1207-1213 (2008).
99. Krivtsov AV, Armstrong SA: MLL translocations, histone modifications and leukaemia stem-cell development. Nature rcvicws 7(11), 823-833 (2007).
100. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100(7), 3983-3988 (2003).
101. Singh SK, Hawkins C, Clarke ID et al.: Identification of human brain tumour initiating cells. Nature 432(7015), 396-401 (2004).
102. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65(23), 10946-10951 (2005).
103. Fang D, Nguyen TK, Leishear K et al.: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65(20), 9328-9337 (2005).
104. Schatton T, Murphy GF, Frank NY et al.: Identification of cells initiating human melanomas. Nature 451 (7176), 345-349 (2008).
105. Kim CF, Jackson EL, Woolfenden AE et al.: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6), 823-835 (2005).
106. Ma S, Chan KW, Hu L et al.: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132(7), 2542-2556 (2007).
107. Yin S, Li J, Hu C et al.: CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 120(7), 1444-1450(2007).
108. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al.: Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123), 111-115(2007).
109. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123), 106-110 (2007).
110. Prince ME, Sivanandan R, Kaczorowski A et al.: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 104(3), 973-978 (2007).
111. Li C, Heidt DG, Dalerba P et al.: Identification of pancreatic cancer stem cells. Cancer Res. 67(3), 1030-1037 (2007).
112. Ferrandina G, Bonanno G, Pierelli L et al.: Expression of CD133-1 and CD133-2 in ovarian cancer. Int. J. Gynecol. Cancer 18(3), 506-514 (2008).
113. Zhang S, Balch C, Chan MW et al.: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68(11), 4311-4320 (2008).
114. Fabian A, Barok M, Vereb G, Szollosi J: Die hard: are cancer stem cells the Bruce Willises of tumor biology? Cytometry A 75(1), 67-74 (2009).
115. Barnhart BC, Simon MC: Metastasis and stem cell pathways. Cancer Metastasis Rev. 26(2), 261-271 (2007).
116. Weissman IL: Normal and neoplastic stem cells. Novartis Found. Symp. 265, 35-50; discussion 50-54, 92-97 (2005).
117. Ivanova N, Dobrin R, Lu R et al.: Dissecting self-renewal in stem cells with RNA interference. Nature 442(7102), 533-538 (2006).
118. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA: 'Sternness': transcriptional profiling of embryonic and adult stem cells. Science 298(5593), 597-600 (2002).
119. Ivanova NB, Dimos JT, Schaniel C et al.: A stem cell molecular signature. Science 298(5593), 601-604 (2002).
120. Sperger JM, Chen X, Draper JS et al.: Gene-expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl Acad. Sci. USA 100(23), 13350-13355 (2003).
121. Assou S, Le Carrour T, Tondeur S et al.: A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25(4), 961-973 (2007).
122. Muller FJ, Laurent LC, Kostka D et al.: Regulatory networks define phenotypic classes of human stem cell lines. Nature 455(7211), 401-405(2008).
123. Tanaka TS, Kunath T, Kimber WL et al.: Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity. Genome Res. 12(12), 1921-1928(2002).
124. Skottman H, Mikkola M, Lundin K et al.: Gene expression signatures of seven individual human embryonic stem cell lines. Stem cells 23(9), 1343-1356(2005).
125. Ben-Porath I, Thomson MW, Carey VJ et al.: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40(5), 499-507 (2008).
126. Birnie R, Bryce SD, Roome C et al.: Gene-expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol. 9(5), R83 (2008).
127. Klarmann GJ, Hurt EM, Mathews LA et al.: Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin. Exp. Metastasis 26(5), 433-446 (2009).
128. Galie M, Konstantinidou G, Peroni D et al.: Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene 27(18), 2542-2551 (2008).
129. Charafe-Jauffret E, Ginestier C, Iovino F et al: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69(4), 1302-1313 (2009).
130. Ke XS, Qu Y, Rostad K et al.: Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS ONE 4(3). E4687(2009).
131. Glinsky GV: 'Sternness' genomics law governs clinical behavior of human cancer: implications for decision making in disease management. J. Clin. Oncol. 26(17), 2846-2853 (2008).
132. Yu J, Yu J, Rhodes DR et al.: A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Res. 67(22), 10657-10663 (2007).
133. Metsuyanim S, Pode-Shakked N, Schmidt-Ott KM et al.: Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes. Stem Cells 26(7), 1808-1817 (2008).
134. Calvisi DF, Ladu S, Gorden A et al.: Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. 117(9), 2713-2722 (2007).
135. Suzuki K, Suzuki I, Leodolter A et al.: Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9(3), 199-207 (2006).
136. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3(6), 415-428 (2002).
137. Baylin SB, Ohm JE: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer6(2), 107-116(2006).
138. Issa JP: CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4(12), 988-993 (2004).
139. Bloushtain-Qimron N, Yao J, Snyder EL et al.: Cell type-specific DNA methylation patterns in the human breast. Proc. Natl Acad. Sci. USA 105(37), 14076-14081 (2008).
140. Shipitsin M, Campbell LL, Argani P et al: Molecular definition of breast tumor heterogeneity. Cancer Cell 11(3), 259-273 (2007).
141. Mohinta S, Wu H, Chaurasia P, Watabe K: Wnt pathway and breast cancer. Front. Biosci. 12, 4020-4033 (2007).
142. Klarmann GJ, Decker A, Farrar WL: Epigenetic gene silencing in the Wnt pathway in breast cancer. Epigenetics 3(2), 59 (2008).
143. Lindvall C, Bu W, Williams BO, Li Y: Wnt signaling, stem cells, and the cellular origin of breast cancer. Stem Cell Rev. 3(2), 157-168 (2007).
144. Cheng AS, Culhane AC, Chan MW et al.: Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res. 68(6), 1786-1796 (2008).
145. Calvanese V, Horrillo A, Hmadcha A et al.: Cancer genes hypermethylated in human embryonic stem cells. PLoS ONE 3 (9), E3294 (2008).
146. Meissner A, Mikkelsen TS, Gu H et al: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454(7205), 766-770 (2008).
147. Widschwendter M, Fiegl H, Egle D et al: Epigenetic stem cell signature in cancer. Nat. Genet. 39(2), 157-158 (2007).
148. Schuebel K, Chen W, Baylin SB: CIMPle origin for promoter hypermethylation in colorectal cancer? Nat. Genet. 38(7), 738-740 (2006).
149. Brunner AL, Johnson DS, Kim SW et al.: Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res. 19(6), 1044-1056(2009).
150. Hahn MA, Hahn T, Lee DH et al.: Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 68(24), 10280-10289 (2008).
151. McGarvey KM, Van Neste L, Cope L et al.: Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells. Cancer Res. 68(14), 5753-5759 (2008).
152. Gartel AL, Kandel ES: RNA interference in cancer. Biomol. Eng. 23(1), 17-34 (2006).
153. Nimmo RA, Slack FJ: An elegant miRror: microRNAs in stem cells, developmental timing and cancer. Chromosoma 118(4), 405-418 (2009).
154. Calin GA, Sevignani C, Dumitru CD et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101(9), 2999-3004 (2004).
155. Lu J, Getz G, Miska EA et al.: MicroRNA expression profiles classify human cancers. Nature 435(7043), 834-838 (2005).
156. Takamizawa J, Konishi H, Yanagisawa K et al.: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64(11), 3753-3756 (2004).
157. Thomson JM, Newman M, Parker JS et al.: Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20(16), 2202-2207 (2006).
158. Lujambio A, Calin GA, Villanueva A et al: A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA 105(36), 13556-13561 (2008).
159. Wang Y, Bleiloch R: Cell cycle regulation by MicroRNAs in embryonic stem cells. Cancer Res. 69(10), 4093-4096 (2009).
160. Yu F, Yao H, Zhu P et al: Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131(6), 1109-1123(2007).
161. Iorio MV, Ferracin M, Liu CG et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65(16), 7065-7070 (2005).
162. Shell S, Park SM, Radjabi AR et al: Let-7 expression defines two differentiation stages of cancer. Proc. Natl Acad. Sci. USA 104(27), 11400-11405(2007).
163. Park SM, Shell S, Radjabi AR et al: Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6(21), 2585-2590 (2007).
164. Shimono Y, Zabala M, Cho RW et al.: Downrcgulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138(3), 592-603 (2009).
165. Su X, Gopalakrishnan V, Stearns D et al.: Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol. Cell. Biol. 26(5), 1666-1678 (2006).
166. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA: International patterns and trends in testis cancer incidence. Int. J. Cancer 115(5), 822-827(2005).
167. Bray F, Richiardi L, Ekbom A et al.: Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int. J. Cancer 118(12), 3099-3111 (2006).
168. Sokoloff MH, Joyce GF, Wise M: Testis cancer. J Urol. 177(6), 2030-2041 (2007).
169. van de Geijn GJ, Hersmus R, Looijenga LH: Recent developments in testicular germ cell tumor research. Birth Defects Res C Embryo Today 87(1), 96-113 (2009).
170. Bulic-Jakus F, Ulamec M, Vlahovic M et al.: Of mice and men: teratomas and teratocarcinomas. Coll. Antropol. 30(4), 921-924 (2006).
171. Korkola JE, Heck S, Olshen AB et al.: In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosomes Cancer 47(1), 43-55 (2008).
172. Korkola JE, Houldsworth J, Chadalavada RS et al.: Downregulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66(2), 820-827 (2006).
173. Netto GJ, Nakai Y, Nakayama M et al.: Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. Mod. Pathol. 21(11), 1337-1344 (2008).
174. Pierce GB: Neoplasms, differentiations and mutations. Am. J. Pathol. 77(1), 103-118 (1974).
175. Kleinsmith LJ, Pierce GB Jr: Multipotentiality of single embryonal carcinoma cells. Cancer Res. 24, 1544-1551 (1964).
176. Damjanov I: From stem cells to germ cell tumors and back. Verh. Dtsch. Ges. Pathol. 88, 39-44 (2004).
177. Andrews PW: From teratocarcinomas to embryonic stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357(1420), 405-417 (2002).
178. Solter D, Skreb N, Damjanov I: Extrauterine growth of mouse egg-cylinders results in malignant teratoma. Nature 227(5257), 503-504 (1970).
179. Mintz B, Illmensee K: Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl Acad. Sci. USA 72(9), 3585-3589 (1975).
180. Lind GE, Skotheim RI, Fraga MF et al.: Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J. Pathol. 210(4), 441-449 (2006).
181. Honorio S, Agathanggelou A, Wernett N et al.: Frequent epigenetic inactivation of the RASSFIA tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 22(3), 461-466 (2003).
182. Kawakami T, Okamoto K, Kataoka A et al.: Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas. Genes Chromosomes Cancer 38(1), 97-101 (2003).
183. De Jong J, Weeda S, Gillis AJ, Oosterhuis JW, Looijenga LH: Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors. Oncol. Rep. 18(1), 127-132(2007).
184. Santagata S, Ligon KL, Hornick JL: Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am. J. Surg. Pathol. 31(6), 836-845 (2007).
185. de Jong J, Looijenga LH: Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit. Rev. Oncog. 12(3-4), 171-203 (2006).
186. West JA, Viswanathan SR, Yabuuchi A et al.: A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 460(7257), 909-913 (2009).
187. Glinsky GV, Berezovska O, Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115(6), 1503-1521 (2005)